UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Obesity on High-density Lipoprotein Metabolism

Obesity (Silver Spring, Md.), 2007-12, Vol.15 (12), p.2875-2888

2007

Volltextzugriff (PDF)

Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein Receptor Suppression Mediated in Part by Proprotein Convertase Subtilisin/Kexin Type 9

Journal of the American College of Cardiology, 2012-05, Vol.59 (19), p.1697-1705

2012

Volltextzugriff (PDF)

Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor-Dependent and -Independent Mechanisms

Circulation (New York, N.Y.), 2014-07, Vol.130 (5), p.431-441

2014

Volltextzugriff (PDF)

Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice

eLife, 2017-02, Vol.6

2017

Volltextzugriff (PDF)

Local effects of human PCSK9 on the atherosclerotic lesion

The Journal of pathology, 2016-01, Vol.238 (1), p.52-62

2016

Volltextzugriff (PDF)

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms

Cardiovascular research, 2016-05, Vol.110 (2), p.268-278

2016

Volltextzugriff (PDF)

Human Resistin Stimulates Hepatic Overproduction of Atherogenic ApoB-Containing Lipoprotein Particles by Enhancing ApoB Stability and Impairing Intracellular Insulin Signaling

Circulation research, 2011-03, Vol.108 (6), p.727-742

2011

Volltextzugriff (PDF)

Decreased Plasma Cholesterol and Hypersensitivity to Statins in Mice Lacking Pcsk9

Proceedings of the National Academy of Sciences - PNAS, 2005-04, Vol.102 (15), p.5374-5379

2005

Volltextzugriff (PDF)

Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)

PloS one, 2011-07, Vol.6 (7), p.e22112-e22112

2011

Volltextzugriff (PDF)

Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2-Deficient Mouse Model of Congenital Generalized Lipodystrophy

Cell metabolism, 2009-02, Vol.9 (2), p.165-176

2009

Volltextzugriff (PDF)

Lower LDL is better - can this be achieved with CETP inhibition therapy?

Expert review of cardiovascular therapy, 2020-01, Vol.18 (1), p.1-5

Rashid, Shirya

2020

Volltextzugriff (PDF)

Dr. Mladen Vranic-A Legend in Diabetes Research: 1930-2019

Diabetes care, 2020-09, Vol.43 (9), p.1997-2000

2020

Volltextzugriff (PDF)

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity

Clinical biochemistry, 2003-09, Vol.36 (6), p.421-429

2003

Volltextzugriff (PDF)

Dr. Mladen Vranic Remembered

Canadian journal of diabetes, 2019-12, Vol.43 (8), p.549-549

Rashid, Shirya

2019

Volltextzugriff (PDF)

On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects

Atherosclerosis, 2015-02, Vol.238 (2), p.264-270

2015

Volltextzugriff (PDF)

Should cholesterol-lowering medications be available in Canada without a prescription?

Canadian journal of cardiology, 2007-03, Vol.23 (3), p.189-193

Rashid, Shirya, PhD

2007

Volltextzugriff (PDF)

Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin

World journal of cardiology, 2009-12, Vol.1 (1), p.41-45

Rashid, Shirya

2009

Volltextzugriff (PDF)

Abstract 14630: Elevated CETP Activity is Associated With Low, Dysfunctional HDL in High Cardiovascular Risk South Asians

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A14630-A14630

2015

Volltextzugriff (PDF)

Abstract 14589: Adiponectin Inhibits Hepatic Production of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both LDL-Receptor Dependent and Independent Mechanisms

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A14589-A14589

2015

Volltextzugriff (PDF)

Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines

Journal of lipid research, 2005-08, Vol.46 (8), p.1668-1677

2005

Volltextzugriff (PDF)

Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation

Arteriosclerosis, thrombosis, and vascular biology, 2002-03, Vol.22 (3), p.483-487

2002

Volltextzugriff (PDF)

What do high blood resistin levels mean for patients on statin therapy?

Expert review of cardiovascular therapy, 2013-03, Vol.11 (3), p.255-257

Rashid, Shirya

2013

Volltextzugriff (PDF)

The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states

Journal of diabetes and its complications, 2002, Vol.16 (1), p.24-28

2002

Volltextzugriff (PDF)

Abstract 9763: Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein (LDL) Receptor Suppression Mediated by PCSK9

Circulation (New York, N.Y.), 2011-11, Vol.124 (suppl_21)

2011

Volltextzugriff (PDF)

Statins and primary prevention: Is all the evidence in?

Canadian journal of cardiology, 2008-04, Vol.24 (4), p.301-303

2008

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(48)
Dissertationen
(2)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of Obesity on High-density Lipoprotein Metabolism

Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein Receptor Suppression Mediated in Part by Proprotein Convertase Subtilisin/Kexin Type 9

Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor-Dependent and -Independent Mechanisms

Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice

Local effects of human PCSK9 on the atherosclerotic lesion

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms

Human Resistin Stimulates Hepatic Overproduction of Atherogenic ApoB-Containing Lipoprotein Particles by Enhancing ApoB Stability and Impairing Intracellular Insulin Signaling

Decreased Plasma Cholesterol and Hypersensitivity to Statins in Mice Lacking Pcsk9

Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)

Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2-Deficient Mouse Model of Congenital Generalized Lipodystrophy

Lower LDL is better - can this be achieved with CETP inhibition therapy?

Dr. Mladen Vranic-A Legend in Diabetes Research: 1930-2019

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity

Dr. Mladen Vranic Remembered

On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects

Should cholesterol-lowering medications be available in Canada without a prescription?

Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin

Abstract 14630: Elevated CETP Activity is Associated With Low, Dysfunctional HDL in High Cardiovascular Risk South Asians

Abstract 14589: Adiponectin Inhibits Hepatic Production of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both LDL-Receptor Dependent and Independent Mechanisms

Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines

Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation

What do high blood resistin levels mean for patients on statin therapy?

The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states

Abstract 9763: Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein (LDL) Receptor Suppression Mediated by PCSK9

Statins and primary prevention: Is all the evidence in?

Suchergebnisse filtern